The drinks industry is seeing a surge in innovation aimed at consumers using GLP-1 medications. However, this rapid development is currently happening faster than the regulatory frameworks can keep up.
According to FoodNavigator Europe, this gap is creating significant challenges for manufacturers attempting to navigate the legal landscape while meeting new consumer needs.
